Cover of Biosimilarity

An edition of Biosimilarity (2018)

Biosimilarity

The FDA Perspective

By Sarfaraz K. Niazi

0 (0 Ratings)

0 Want to read0 Currently reading0 Have read

0 Want to read0 Currently reading0 Have read

Publish Date

2018

Publisher

Taylor & Francis Group,CRC Press

Language

eng

Pages

398

Description:

subjects: United states, food and drug administration, Price regulation, Administrative agencies, United States Government Agencies, United States, Biosimilar Pharmaceuticals, Government Regulation, Drug Approval, United States. Food and Drug Administration